Stock Track | Tandem Diabetes Care Plunges After Q3 Earnings Miss Amid Profitability Concerns

Stock Track11-07

Tandem Diabetes Care (NASDAQ: TNDM) stock plunged over 8% in after-hours trading on November 6, 2024, despite reporting better-than-expected third-quarter revenue. The sell-off appears to be driven by concerns over the company's profitability and growth prospects.

For the third quarter of 2024, Tandem reported an operating loss of $26.1 million and a net loss of $23.3 million, or $0.35 per share. While the company's net loss improved year-over-year, it seems to have fallen short of investors' expectations.

On the positive side, Tandem's revenue grew by 31.45% year-over-year to $244 million, surpassing the analyst consensus estimate of $223.7 million. The company's sales growth was driven by strong demand for its insulin pumps and supplies, both in the United States and internationally.

However, despite the robust revenue growth, Tandem's profitability remains a concern. The company's guidance for the full year 2024 suggests that it expects to be around breakeven on an adjusted EBITDA basis, which may have disappointed some investors who were hoping for a stronger path to profitability.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195933240?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-07 09:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195933240","market":"hk","top_or_hot":-1,"title":"Stock Track | Tandem Diabetes Care Plunges After Q3 Earnings Miss Amid Profitability Concerns","media":"Stock Track","content":"<p>Tandem Diabetes Care (NASDAQ: TNDM) stock plunged over 8% in after-hours trading on November 6, 2024, despite reporting better-than-expected third-quarter revenue. The sell-off appears to be driven by concerns over the company's profitability and growth prospects.</p>\n\n<p>For the third quarter of 2024, Tandem reported an operating loss of $26.1 million and a net loss of $23.3 million, or $0.35 per share. While the company's net loss improved year-over-year, it seems to have fallen short of investors' expectations.</p>\n\n<p>On the positive side, Tandem's revenue grew by 31.45% year-over-year to $244 million, surpassing the analyst consensus estimate of $223.7 million. The company's sales growth was driven by strong demand for its insulin pumps and supplies, both in the United States and internationally.</p>\n\n<p>However, despite the robust revenue growth, Tandem's profitability remains a concern. The company's guidance for the full year 2024 suggests that it expects to be around breakeven on an adjusted EBITDA basis, which may have disappointed some investors who were hoping for a stronger path to profitability.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tandem Diabetes Care Plunges After Q3 Earnings Miss Amid Profitability Concerns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tandem Diabetes Care Plunges After Q3 Earnings Miss Amid Profitability Concerns\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-07 09:23 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tandem Diabetes Care (NASDAQ: TNDM) stock plunged over 8% in after-hours trading on November 6, 2024, despite reporting better-than-expected third-quarter revenue. The sell-off appears to be driven by...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNDM","symbol_name":"糖尿病保健","start_time":0,"source_url":"","article_id":"1195933240","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195933240","pubTimestamp":1730942588,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tandem Diabetes Care  stock plunged over 8% in after-hours trading on November 6, 2024, despite reporting better-than-expected third-quarter revenue. The sell-off appears to be driven by concerns over the company's profitability and growth prospects.For the third quarter of 2024, Tandem reported an operating loss of $26.1 million and a net loss of $23.3 million, or $0.35 per share. While the company's net loss improved year-over-year, it seems to have fallen short of investors' expectations.On t","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNDM":"糖尿病保健"},"translate_title":"由于盈利能力担忧，第三季度盈利未达预期，Tandem Diabetes Care股价暴跌","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNDM":1},"content_text":"Tandem Diabetes Care (NASDAQ: TNDM) stock plunged over 8% in after-hours trading on November 6, 2024, despite reporting better-than-expected third-quarter revenue. The sell-off appears to be driven by concerns over the company's profitability and growth prospects.\nFor the third quarter of 2024, Tandem reported an operating loss of $26.1 million and a net loss of $23.3 million, or $0.35 per share. While the company's net loss improved year-over-year, it seems to have fallen short of investors' expectations.\nOn the positive side, Tandem's revenue grew by 31.45% year-over-year to $244 million, surpassing the analyst consensus estimate of $223.7 million. The company's sales growth was driven by strong demand for its insulin pumps and supplies, both in the United States and internationally.\nHowever, despite the robust revenue growth, Tandem's profitability remains a concern. The company's guidance for the full year 2024 suggests that it expects to be around breakeven on an adjusted EBITDA basis, which may have disappointed some investors who were hoping for a stronger path to profitability.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195933240"}